Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Monetizing Science: Turning an Asset into Value through IPOs

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. 

Panelists include:

  • David Epstein, Flagship Pioneering
  • Dan Passeri, Cue Biopharma

Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com